Inventor · disambiguated record
Andre Faldt
Also filed as: FALDT ANDRE · FALDT ANDRÉ
13 granted patents·5 pending applications·127 citations·filing 2007–2022
93Inventor score
Top patents by PatentIndex Score
18 records- 0194US8969355B21-[2-(2,4 dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1a activity for the treatment of cognitive impairmentLUNDBECK & CO AS H·Filed 2014·Granted Mar 3, 2015·15 cites·7 claims
- 0294US8722684B21-[2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairmentBANG-ANDERSEN BENNY·Filed 2007·Granted May 13, 2014·31 cites·8 claims
- 0392US9125908B21-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairmentLUNDBECK & CO AS H·Filed 2014·Granted Sep 8, 2015·11 cites·10 claims
- 0491US9227946B21-[2-(2,4 dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1a activity for the treatment of cognitive impairmentLUNDBECK & CO AS H·Filed 2014·Granted Jan 5, 2016·9 cites·5 claims
- 0591US9125909B21-[2-(2,4 dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairmentLUNDBECK & CO AS H·Filed 2014·Granted Sep 8, 2015·9 cites·11 claims
- 0691US9125910B21-[2-(2,4 dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairmentLUNDBECK & CO AS H·Filed 2014·Granted Sep 8, 2015·9 cites·10 claims
- 0790US9861630B11-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairmentH LUNDBECK AS·Filed 2017·Granted Jan 9, 2018·5 cites·16 claims
- 0890US9101626B2Process for preparing 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine or pharmaceutically acceptable salt thereofLUNDBECK & CO AS H·Filed 2014·Granted Aug 11, 2015·12 cites·28 claims
- 0989US9095588B2Process for preparing 1-[2-(2,4-dimethylphenysulfanyl)-pheny]piperazine or pharmaceutically acceptable salt thereofLUNDBECK & CO AS H·Filed 2014·Granted Aug 4, 2015·10 cites·17 claims
- 1086US8299095B2Crystalline forms of 4-[2-(4-methylphenylsulfanyl)-phenyl] piperidine with combined serotonin and norepinephrine reuptake inhibition and uses thereofBANG-ANDERSEN BENNY·Filed 2007·Granted Oct 30, 2012·8 cites·18 claims
- 1183US2023021520A11-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-ht3 and 5-ht1a activity for the treatment of cognitive impairmentH LUNDBECK AS·Filed 2022·Application pending·0 cites
- 1282US9315459B2Crystalline forms of 4-[2-(4-methylphenylsulfanyl)-phenyl] piperidineLUNDBECK & CO AS H·Filed 2014·Granted Apr 19, 2016·4 cites·17 claims
- 1378US9908894B2Methods for the preparation of 1,3-benzodioxole heterocyclic compoundsLEO PHARMA AS·Filed 2015·Granted Mar 6, 2018·4 cites·9 claims
- 1473US11458134B21-[2-(2,4-dimeihylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairmentH LUNDBECK AS·Filed 2019·Granted Oct 4, 2022·0 cites·10 claims
- 1568US2018333408A11-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-ht3 and 5-ht1a activity for the treatment of cognitive impairmentH LUNDBECK AS·Filed 2017·Application pending·0 cites
- 1659US2016083359A11-[2-(2,4-DIMETHYLPHENYLSULFANYL)-PHENYL]PIPERAZINE AS A COMPOUND With COMBINED SEROTONIN REUPTAKE, 5-HT3 AND 5-HT1A ACTIVITY FOR THE TREATMENT OF COGNITIVE IMPAIRMENTLUNDBECK & CO AS H·Filed 2015·Application pending·0 cites
- 1752US2017037006A1Crystalline forms of 4-[2-(4-methylphenylsulfanyl)-phenyl] piperidineH LUNDBECK AS·Filed 2016·Application pending·0 cites
- 1851US2011039890A14-[2,3-Difluoro-6-(2-fluoro-4-methyl-phenylsulfanyl)-phenyl]-piperidineLUNDBECK & CO AS H·Filed 2008·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →